-
EP4136121
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4136121
| EP4136121 - SYSTEMS, MATERIALS, AND METHODS FOR REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC) FOR MONITORING FORMATION OF MULTI-SPECIFIC MOLECULES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.09.2023 Database last updated on 24.07.2024 | |
| Former | Request for examination was made Status updated on 20.01.2023 | ||
| Former | The international publication has been made Status updated on 22.10.2021 | ||
| Former | unknown Status updated on 03.05.2021 | Most recent event Tooltip | 22.07.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US | [2023/08] | Inventor(s) | 01 /
MARTOSELLA, James 200 Great Valley Parkway Malvern, PA 19355 / US | 02 /
FELICIANO-CARDONA, Jessika S. 200 Great Valley Parkway Malvern, PA 19355 / US | 03 /
ELOVE, Gulnur 200 Great Valley Parkway Malvern, PA 19355 / US | [2023/08] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2023/08] | Application number, filing date | 21720575.6 | 15.04.2021 | [2023/08] | WO2021IB53127 | Priority number, date | US202063010907P | 16.04.2020 Original published format: US 202063010907 P | US202063010912P | 16.04.2020 Original published format: US 202063010912 P | US202063010920P | 16.04.2020 Original published format: US 202063010920 P | US202063010926P | 16.04.2020 Original published format: US 202063010926 P | [2023/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021209953 | Date: | 21.10.2021 | Language: | EN | [2021/42] | Type: | A1 Application with search report | No.: | EP4136121 | Date: | 22.02.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.10.2021 takes the place of the publication of the European patent application. | [2023/08] | Search report(s) | International search report - published on: | EP | 21.10.2021 | Classification | IPC: | C07K16/46, G01N30/88, G01N30/36, G01N30/30, G01N30/02 | [2023/08] | CPC: |
C07K16/468 (EP,US);
G01N30/34 (EP,US);
B01D15/366 (EP,US);
C07K16/28 (US);
C07K16/2803 (US);
C07K16/2809 (US);
C07K16/2866 (US);
C07K16/2878 (US);
C07K2317/10 (EP,US);
C07K2317/31 (US);
C07K2317/55 (US);
G01N2030/027 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/08] | Title | German: | SYSTEME, MATERIALIEN UND VERFAHREN FÜR UMKEHRPHASEN-HOCHLEISTUNGSFLÜSSIGKEITSCHROMATOGRAPHIE (RP-HPLC) ZUR ÜBERWACHUNG DER BILDUNG MULTISPEZIFISCHER MOLEKÜLE | [2023/08] | English: | SYSTEMS, MATERIALS, AND METHODS FOR REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC) FOR MONITORING FORMATION OF MULTI-SPECIFIC MOLECULES | [2023/08] | French: | SYSTÈMES, MATÉRIELS ET MÉTHODES POUR UNE CHROMATOGRAPHIE EN PHASE LIQUIDE HAUTE PERFORMANCE EN PHASE INVERSÉE (CLHP-PI) POUR LA SURVEILLANCE DE LA FORMATION DE MOLÉCULES MULTI-SPÉCIFIQUES | [2023/08] | Entry into regional phase | 15.11.2022 | National basic fee paid | 15.11.2022 | Designation fee(s) paid | 15.11.2022 | Examination fee paid | Examination procedure | 15.11.2022 | Amendment by applicant (claims and/or description) | 15.11.2022 | Examination requested [2023/08] | 15.11.2022 | Date on which the examining division has become responsible | 11.09.2023 | Despatch of a communication from the examining division (Time limit: M04) | 19.01.2024 | Reply to a communication from the examining division | 02.02.2024 | Despatch of a communication from the examining division (Time limit: M04) | 14.05.2024 | Reply to a communication from the examining division | 22.05.2024 | Despatch of a communication from the examining division (Time limit: M02) | 22.07.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 14.03.2023 | Renewal fee patent year 03 | 13.03.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2005161399 (DILLON THOMAS [US], et al) [X] 1,4-12,28,29 * see [014, 016-023, 025, 073-074, 114-115] * [Y] 19-24,27; | [Y]EP1645564 (AGILENT TECHNOLOGIES INC [US]) [Y] 2,3,14,15* see e.g. D7, [050-051, 058-063] *; | [XY] - DIMASI NAZZARENO ET AL, "Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain", MABS, US, vol. 9, no. 3, doi:10.1080/19420862.2016.1277301, ISSN 1942-0862, (20170403), pages 438 - 454, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384712/pdf/kmab-09-03-1277301.pdf, XP055822615 [X] 1,4-6,13,16-18,25,26,28,29 * see abstract, p. 439-440, 450 * [Y] 2,3,14,15,19-24,27 DOI: http://dx.doi.org/10.1080/19420862.2016.1277301 | [XY] - GIESE GLEN ET AL, "Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies", BIOTECHNOLOGY PROGRESS, vol. 34, no. 2, doi:10.1002/btpr.2590, ISSN 8756-7938, (20180117), pages 397 - 404, URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbtpr.2590, XP055822613 [X] 1,4-6,13,16-18,25,26,28,29 * see p. 398-399, Fig. 1 * [Y] 2,3,14,15,19-24,27 DOI: http://dx.doi.org/10.1002/btpr.2590 | [XY] - MANIKWAR PRAKASH ET AL, "Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical Stability", JOURNAL OF PHARMACEUTICAL SCIENCES, US, vol. 109, no. 1, doi:10.1016/j.xphs.2019.06.025, ISSN 0022-3549, (20190707), pages 220 - 232, URL: https://www.jpharmsci.org/article/S0022-3549(19)30428-9/pdf, XP055794177 [X] 1,4,13,16,25,26,28,29 * p. 222, Figs. 1, 8 * [Y] 2,3,14,15,19-24,27 DOI: http://dx.doi.org/10.1016/j.xphs.2019.06.025 | [A] - John Dolan, "A Guide to HPLC and LC-MS Buffer Selection", HPLC Columns, (20060705), URL: https://www.researchgate.net/file.PostFileLoader.html?id=57602f96b0366de7491f6a17&assetKey=AS:372915662016512@1465921430626, (20161110), XP055318419 [A] 1-29 * see p. 7 * | [Y] - AMARAL MARTA ET AL, "Engineered Technologies and Bioanalysis of multispecific Antibody Formats", JOURNAL OF APPLIED BIOANALYSIS, vol. 6, no. 1, doi:10.17145/jab.20.005, (20200131), pages 26 - 51, URL: https://betasciencepress-publishing.com/wp-content/uploads/1017145_jab_pdf/JAB20005-Engineered-Technologies-and-Bioanalysis-of-multispecific-Antibody-Formats.pdf, XP055822537 [Y] 27 * see p. 33, 39 and Table 2 * DOI: http://dx.doi.org/10.17145/jab.20.005 | by applicant | WO2006028936 | US2009182127 | US2010015133 | US2010028637 | US2011123532 | WO2011131746 | US2012149876 | US2013195849 |